X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-06 | EOLS | Beaver Sandra | CFO | S - Sale | $14.98 | -3,276 | 148,502 | -2% | -$49,074 | ||||||
2024-08-30 | EOLS | Yamagishi-Dressler Tomoko | CMO | S - Sale | $15.85 | -5,631 | 82,375 | -6% | -$89,251 | ||||||
DM | 2024-06-04 | EOLS | Moatazedi David | See Remarks | S - Sale+OE | $12.74 | -471,432 | 533,349 | -47% | -$6,005,628 | |||||
2024-06-03 | EOLS | Malik Vikram | Dir | S - Sale | $12.96 | -7,500 | 246,514 | -3% | -$97,203 | ||||||
M | 2024-05-13 | EOLS | Gill David N | Dir | S - Sale | $12.64 | -10,361 | 33,964 | -23% | -$131,010 | |||||
2024-05-13 | EOLS | Malik Vikram | Dir | S - Sale | $12.93 | -28,000 | 254,014 | -10% | -$362,012 | ||||||
2024-05-10 | EOLS | Moatazedi David | See Remarks | S - Sale | $12.72 | -16,051 | 673,563 | -2% | -$204,127 | ||||||
2024-05-10 | EOLS | Avelar Rui | See Remarks | S - Sale | $12.72 | -3,441 | 368,847 | -1% | -$43,761 | ||||||
2024-05-10 | EOLS | Beaver Sandra | CFO | S - Sale | $12.72 | -2,423 | 151,778 | -2% | -$30,814 | ||||||
2024-03-27 | EOLS | Moatazedi David | See Remarks | S - Sale | $13.86 | -6,236 | 689,614 | -1% | -$86,431 | ||||||
2024-03-19 | EOLS | Avelar Rui | See Remarks | S - Sale | $13.92 | -27,603 | 372,288 | -7% | -$384,350 | ||||||
2024-03-19 | EOLS | Beaver Sandra | CFO | S - Sale | $13.92 | -5,672 | 154,201 | -4% | -$78,978 | ||||||
2024-03-19 | EOLS | Moatazedi David | See Remarks | S - Sale | $13.92 | -96,566 | 695,850 | -12% | -$1,344,604 | ||||||
2024-02-22 | EOLS | Moatazedi David | See Remarks | S - Sale | $13.08 | -7,706 | 792,416 | -1% | -$100,804 | ||||||
2024-02-22 | EOLS | Avelar Rui | See Remarks | S - Sale | $13.08 | -1,821 | 399,891 | 0% | -$23,821 | ||||||
2024-02-22 | EOLS | Beaver Sandra | CFO | S - Sale | $13.08 | -1,821 | 159,873 | -1% | -$23,821 | ||||||
2024-01-30 | EOLS | Parschauer Karah Herdman | Dir | S - Sale | $13.14 | -11,931 | 31,243 | -28% | -$156,733 | ||||||
M | 2023-12-06 | EOLS | Moatazedi David | See Remarks | S - Sale | $9.95 | -82,648 | 603,944 | -12% | -$822,396 | |||||
2023-10-16 | EOLS | Medytox Inc. | Former 10% Owner | S - Sale | $7.50 | -1,690,663 | 3,381,326 | -33% | -$12,679,973 | ||||||
2023-09-06 | EOLS | Beaver Sandra | CFO | S - Sale | $9.70 | -3,178 | 113,368 | -3% | -$30,827 | ||||||
2023-08-16 | EOLS | Avelar Rui | See Remarks | S - Sale | $10.27 | -2,211 | 353,386 | -1% | -$22,707 | ||||||
2023-08-16 | EOLS | Beaver Sandra | CFO | S - Sale | $10.27 | -2,211 | 116,546 | -2% | -$22,707 | ||||||
2023-08-16 | EOLS | Moatazedi David | See Remarks | S - Sale | $10.27 | -14,778 | 686,592 | -2% | -$151,770 | ||||||
2023-08-15 | EOLS | Malik Vikram | Dir | P - Purchase | $7.41 | +174,967 | 275,550 | +174% | +$1,296,505 | ||||||
2023-03-27 | EOLS | Moatazedi David | See Remarks | S - Sale | $8.47 | -6,110 | 609,567 | -1% | -$51,752 | ||||||
2023-03-14 | EOLS | Moatazedi David | See Remarks | S - Sale | $8.47 | -64,211 | 615,677 | -9% | -$543,797 | ||||||
2023-03-14 | EOLS | Avelar Rui | See Remarks | S - Sale | $8.47 | -14,906 | 335,925 | -4% | -$126,237 | ||||||
2023-02-17 | EOLS | Alphaeon 1 LLC | 10% | S - Sale | $8.40 | -1,850,000 | 4,214,871 | -31% | -$15,540,000 | ||||||
2023-02-07 | EOLS | Medytox Inc. | 10% | S - Sale | $8.50 | -2,187,511 | 5,071,989 | -30% | -$18,593,844 | ||||||
M | 2021-08-12 | EOLS | Medytox Inc. | 10% | P - Purchase | $11.04 | +37,043 | 7,259,500 | +1% | +$408,839 | |||||
2023-01-20 | EOLS | Medytox Inc. | 10% | S - Sale | $11.04 | -37,043 | 7,259,500 | -1% | -$408,955 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |